These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

147 related articles for article (PubMed ID: 6439896)

  • 1. Acute complications associated with insulin infusion pump therapy. Report of experience with 161 patients.
    Mecklenburg RS; Benson EA; Benson JW; Fredlund PN; Guinn T; Metz RJ; Nielsen RL; Sanner CA
    JAMA; 1984 Dec; 252(23):3265-9. PubMed ID: 6439896
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Frequency of diabetic ketoacidosis and hypoglycemic coma during treatment with continuous subcutaneous insulin infusion. Audit of medical care.
    Bending JJ; Pickup JC; Keen H
    Am J Med; 1985 Dec; 79(6):685-91. PubMed ID: 3934967
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Acute complications associated with the use of insulin infusion pumps.
    Mecklenburg RS
    Diabetes Educ; 1989; 15(1):40-3. PubMed ID: 2491989
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Complications of insulin pump therapy: the effect of insulin preparation.
    Mecklenburg RS; Guinn TS
    Diabetes Care; 1985; 8(4):367-70. PubMed ID: 3930189
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Diabetic Ketoacidosis Among Patients Treated With Continuous Subcutaneous Insulin Infusion.
    Dogan ADA; Jørgensen UL; Gjessing HJ
    J Diabetes Sci Technol; 2017 May; 11(3):631-632. PubMed ID: 27595713
    [No Abstract]   [Full Text] [Related]  

  • 6. Variability of Basal Rate Profiles in Insulin Pump Therapy and Association with Complications in Type 1 Diabetes Mellitus.
    Laimer M; Melmer A; Mader JK; Schütz-Fuhrmann I; Engels HR; Götz G; Pfeifer M; Hermann JM; Stettler C; Holl RW
    PLoS One; 2016; 11(3):e0150604. PubMed ID: 26938444
    [TBL] [Abstract][Full Text] [Related]  

  • 7. [Ketoacidosis in long-term therapy with insulin pumps. Incidence, causes, circumstances].
    Walter H; Günther A; Timmler R; Mehnert H
    Med Klin (Munich); 1989 Dec; 84(12):565-8. PubMed ID: 2516236
    [TBL] [Abstract][Full Text] [Related]  

  • 8. [Treatment with insulin pump during hospital care should be questioned. Three cases illustrate the risk of ketoacidosis].
    Gubrianska D; Moberg E; Palmér M
    Lakartidningen; 2009 Aug 5-18; 106(32-33):1967-8. PubMed ID: 19764373
    [No Abstract]   [Full Text] [Related]  

  • 9. Sudden death due to diabetic ketoacidosis following power failure of an insulin pump: Autopsy and pump data.
    Kjærulff MLBG; Astrup BS
    J Forensic Leg Med; 2019 Apr; 63():34-39. PubMed ID: 30856551
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Insulin pump-associated adverse events are common, but not associated with glycemic control, socio-economic status, or pump/infusion set type.
    Ross P; Gray AR; Milburn J; Kumarasamy IM; Wu F; Farrand S; Armishaw J; Wiltshire E; Rayns J; Tomlinson P; Wheeler BJ
    Acta Diabetol; 2016 Dec; 53(6):991-998. PubMed ID: 27585938
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Effect of sensor-augmented insulin pump therapy and automated insulin suspension vs standard insulin pump therapy on hypoglycemia in patients with type 1 diabetes: a randomized clinical trial.
    Ly TT; Nicholas JA; Retterath A; Lim EM; Davis EA; Jones TW
    JAMA; 2013 Sep; 310(12):1240-7. PubMed ID: 24065010
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Diabetic ketoacidosis caused by exposure of insulin pump to heat and sunlight.
    Pryce R
    BMJ; 2009 Jan; 338():a2218. PubMed ID: 19124546
    [No Abstract]   [Full Text] [Related]  

  • 13. Pharmacokinetic and clinical aspects of intensified subcutaneous insulin therapy.
    Lauritzen T
    Dan Med Bull; 1985 May; 32(2):104-18. PubMed ID: 3924487
    [No Abstract]   [Full Text] [Related]  

  • 14. Fields of application of continuous subcutaneous insulin infusion in the treatment of diabetes and implications in the use of rapid-acting insulin analogues.
    Pitocco D; Rizzi A; Scavone G; Tanese L; Zaccardi F; Manto A; Ghirlanda G
    Minerva Endocrinol; 2013 Sep; 38(3):321-8. PubMed ID: 24126552
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Factors related to discontinuation of continuous subcutaneous insulin-infusion therapy.
    Guinn TS; Bailey GJ; Mecklenburg RS
    Diabetes Care; 1988 Jan; 11(1):46-51. PubMed ID: 3123187
    [TBL] [Abstract][Full Text] [Related]  

  • 16. [Ketoacidosis during insulin pump therapy--an acceptable risk?].
    Walter H; Mehnert H
    Dtsch Med Wochenschr; 1989 May; 114(18):722-5. PubMed ID: 2496966
    [No Abstract]   [Full Text] [Related]  

  • 17. Factitious self-manipulation of the external insulin pump in adolescents with Type 1 diabetes.
    Moreau F; Spizzo H; Bursztejn C; Berthoux V; Agin A; Pinget M; Pasquali JL; Kessler L
    Diabet Med; 2011 May; 28(5):623-4. PubMed ID: 21303404
    [No Abstract]   [Full Text] [Related]  

  • 18. [Diabetic ketoacidosis during insulin pump therapy].
    Walter H; Günther A; Timmler R; Mehnert H
    Dtsch Med Wochenschr; 1989 May; 114(18):706-8. PubMed ID: 2496965
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Diabetic ketoacidosis caused by exposure of insulin to low temperature.
    Minuto N; Tambroni B; Vannati M; Emmanuele V; Russo C; Lorini R; d'Annunzio G
    Diabetes Technol Ther; 2010 Sep; 12(9):745-6. PubMed ID: 20687866
    [No Abstract]   [Full Text] [Related]  

  • 20. Risk and Relevance of Insulin Pump Therapy in the Aetiology of Ketoacidosis in People with Type 1 Diabetes.
    Giessmann LC; Kann PH
    Exp Clin Endocrinol Diabetes; 2020 Nov; 128(11):745-751. PubMed ID: 30049002
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.